+49 30 648 35 164 service@chameleon-pharma.com

Turkey

View of Istambul from the see under the sunset

Featured image: Photo by Engin Yapici on Unsplash

Turkey: a strategic consumer health and pharma market at the border of Europe 

Turkey may be at the border of Europe, but its self-medication and pharma market is at the heart of European strategies as it became an efficient manufacturing hub full of potential. 

Turkey, the land of the Seljuks and Ottomans, is a coun­try at the gate­way between Europe and Asia. Turkey has been a com­pet­i­tive coun­try since the beginning of civilization—and as today’s Pharma indus­try gains momentum there, the coun­try promises qual­ity partnerships, rigorous challenges, and, yes, even more competition.

Turkey has taken many steps towards a work­ing health­care sys­tem. The Health Trans­for­ma­tion Pro­gram, implemented in 2003, aimed at increasing the qual­ity and effi­ciency of the health­care sys­tem and enhancing access to health­care facil­i­ties. 

The Turkish OTC and pharma market is the 18th largest in the world and reached a worth of US$ 7Bn in 2020. The OTC and pharma sales experienced a CAGR of 12% between 2010 and 2020. According to CPC forecasts, the market should be worth US$ 18,7 billion in 2035, at ex-factory levels.

There are many OTC, Med­ical Device and Food Sup­ple­ment com­pa­nies sell­ing West­ern Euro­pean prod­ucts to huge suc­cess. 

Turkey is geographically close to some of the biggest OTC and pharma import markets and has become a manufacturing hub for Europe. As a candidate for the European Union, Turkey also implemented changes regarding drug regulation to align their OTC and pharma market with European countries, making exports easier.

Cur­rently, Turkey has a pop­u­la­tion of nearly 82 mil­lion. In com­par­i­son to the coun­tries surrounding it, this is a rapidly increas­ing birth rate. It’s no stretch to say that Turkey is one of the lead­ing phar­ma­ceu­ti­cal mar­kets in the world, burst­ing at the seams with pos­si­bil­i­ties.

To help you work your way into this teem­ing mar­ket, we at Chameleon Pharma Consulting Group have devel­oped a sys­tem­atic part­ner search process to iden­tify your best-fit­ting part­ner in only 10–12 weeks. The Chameleon Pharma Consulting Group approach will allow you to save time on the ‘get­ting-to-know-you’ meet­ings with pos­si­ble part­ners, as well as cut down on your travel costs and make you feel confident that you have the best part­ner for sales growth. To ana­lyze the Turk­ish mar­ket specif­i­cally, we use a SWOT analy­sis, which always offers many inter­est­ing out­comes. Despite its risks, the Turk­ish mar­ket is loaded with growth and poten­tial. 

CPC Press Releases on Turkey:

Turkey – TRIUMPH country

Turkey OTC and pharma market in 2035

USD 18,65 Billion

OTC and pharma market size, ex-factory

5-7%

OTC and pharma market growth

Turkey in numbers

Total population

Male/Female

Population growth

Birth rate

Mortality rate

Life expectancy

Interested in this market?

We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.